Denali Therapeutics Inc.
Clinical trials sponsored by Denali Therapeutics Inc., explained in plain language.
-
New drug targets genetic Parkinson's in early trial
Disease control Recruiting nowThis study tests an experimental drug called BIIB122 in 50 people who have a specific genetic form of Parkinson's disease (LRRK2-PD). The main goal is to check the drug's safety and how it affects certain markers in the body over 12 weeks. Participants will be randomly assigned t…
Phase: PHASE2 • Sponsor: Denali Therapeutics Inc. • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New hope for Alzheimer's? early trial tests DNL628
Disease control Recruiting nowThis early-stage study tests an experimental drug called DNL628 in people with early Alzheimer's disease. The main goal is to check if the drug is safe and how the body processes it. About 68 participants will receive either the drug or a placebo. This is a first step to see if D…
Phase: PHASE1 • Sponsor: Denali Therapeutics Inc. • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
New pompe drug trial aims for safer treatment
Disease control Recruiting nowThis early-stage trial tests a new drug called DNL952 in 32 adults with late-onset Pompe disease. The main goal is to check safety and how the body processes the drug. Participants include those currently on enzyme therapy and those who haven't had treatment in the past year.
Phase: PHASE1 • Sponsor: Denali Therapeutics Inc. • Aim: Disease control
Last updated May 19, 2026 11:47 UTC